1-akan-2-ol substituted piperazine and piperidine compounds

Details for Australian Patent Application No. 2004303882 (hide)

Owner CV Therapeutics, Inc.

Inventors Ibrahim, Prabha; Rehder, Kenneth; Zablocki, Jeffrey A.; Palle, Venkata; Elzein, Elfatih

Agent Freehills

Pub. Number AU-A-2004303882

PCT Pub. Number WO2005/061470

Priority 60/531,253 18.12.03 US

Filing date 17 December 2004

Wipo publication date 7 July 2005

International Classifications

C07D 277/64 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

6 July 2006 PCT application entered the National Phase

  PCT publication WO2005/061470 Priority application(s): WO2005/061470

15 October 2009 Alteration of Name

  The name of the applicant has been altered to Gilead Palo Alto, Inc.

14 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004303886-Compositions, methods and kits for detecting the nucleic acids of HIV-1 and HIV-2

2004303881-Method of decomposition polymer